{"nct_id":"NCT01499667","title":"Disease Control and Safety in Patients With Relapsing Remitting Multiple Sclerosis (RRMS) Switching From Natalizumab to Fingolimod","status":"TERMINATED","status_verified_date":"2014-08","start_date":"2011-09","start_date_type":null,"primary_completion_date":"2012-11","primary_completion_date_type":"ACTUAL","completion_date":"2012-11","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}